Connect with us

Technology

Insilico Medicine Introduces Biological Age into Virtual Cell Research: Launches Virtual Aging Cell Webpage and Previews Multi-Agent Driven VAC Generation Platform

Published

on

Following a decade of exploration from the 2014 NVIDIA GTC to the PreciousGPT model series, Insilico Medicine presents the industry’s first multi-agent Virtual Aging Cell (VAC) platform with biological age as a core condition.

CAMBRIDGE, Mass., Aug. 14, 2026 /PRNewswire/ — Insilico Medicine (“Insilico”, HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), today announced the launch of its Virtual Aging Cell (VAC) Webpage alongside the preview of the company’s Multi-Agent driven VAC platform.

Virtual cells are digital models that leverage artificial intelligence (AI) and mathematical modeling to computationally simulate cellular biology and its underlying dynamic laws. They offer powerful capabilities to predict drug responses, elucidate disease mechanisms, and support target discovery. Recognized as a frontier technology, virtual cells were named one of the seven technology breakthroughs to watch in 2025 by Nature, quickly becoming a focal point of competitive research for top global teams.

However, most existing models rely predominantly on data collected at isolated time points, capturing cells as static snapshots. Their capacity to simulate dynamic temporal processes—such as cellular differentiation, reprogramming, and aging—as well as multi-scale interactions across biological hierarchies, remains markedly constrained. Living cells are not frozen biological units; rather, they are constantly undergoing dynamic processes including division, differentiation, aging, and environmental response. A cell’s state is intricately shaped by intracellular molecular networks, intercellular communications, tissue microenvironments, and individual background parameters. Consequently, integrating the temporal axis, biological age, and external interventions into a unified computational framework has emerged as a crucial trajectory for the evolution of virtual cell research.

The Virtual Aging Cell (VAC) concept introduced by Insilico directly addresses this emerging frontier. Built around biological age as a core conditional variable, the platform utilizes a multi-agent AI architecture to perform collaborative reasoning across six biological scales—molecular, intracellular, intercellular, tissue, organ, and organism/population. It aims to dynamically simulate cellular differentiation, reprogramming, and aging, offering robust computational support for target identification, cellular fate intervention, novel drug discovery, and geroscience research.

“Every computational model needs a first principle, and ours is biological age,” said Alex Zhavoronkov, PhD, Founder, Co-CEO, and Chief Business Officer of Insilico Medicine. “This has been a decade-long scientific journey, from raising an industry-defining question at NVIDIA GTC in 2014, to teaching AI the language of aging biology with the PreciousGPT series, and now reimagining the virtual cell through agentic AI swarms. The VAC represents the convergence of this thesis: a platform that doesn’t just read biological data, but conditionally generates the very trajectory of life’s evolution. We look forward to collaborating with global pharmaceutical companies and research institutions in modeling virtual cells, virtual systems, and virtual populations across both healthy and diseased states.”

A decade of Foundation: From Virtual Cell Concept to PreciousGPT Series

Insilico’s exploration in virtual cells and geroscience spans a decade.

At the 2014 NVIDIA GTC conference, Insilico first articulated its vision for computational virtual cells, virtual organs, and digital populations, posing a now-famous industry question — “Can NVIDIA help solve aging?” — officially inaugurating the company’s use of high-performance computing and AI to investigate the mechanisms of aging.

To translate this theoretical vision into practice, the company subsequently partnered with BioTime, a pioneer in regenerative medicine and stem cell research, on a deep collaboration called Embryonic.AI, which used Deep Neural Network Ensembles to track and modulate cell differentiation trajectories and cell fate decisions during the Embryonic-to-Fetal Transition (EFT).

In 2017, the two teams published their findings in Oncotarget, confirming that AI algorithms successfully identified COX7A1 as a key transition factor in the embryonic transformation stage. This was not only Insilico’s first experimentally validated AI target discovery result, but also the first demonstration to the field that artificial intelligence could precisely capture the switches governing cell differentiation, reprogramming, and cell conversion, laying the biological foundation for subsequent virtual cell simulation.

With the rapid advancement of large model technology, Dr. Alex Zhavoronkov first proposed applying multimodal Transformers to aging research at the Gordon Research Conference (GRC) in May 2022. To explore the potential of multimodal Transformers and diffusion models in life sciences, the company’s AI team initiated model development that same year, building on years of accumulated expertise in aging biology and multi-omics modeling to progressively construct the PreciousGPT series of scientific foundation models dedicated to aging mechanism analysis and multi-omics generation.

In 2023, Insilico released Precious1GPT, an aging clock based on multimodal Transformers and transfer learning. The model integrated DNA methylation (epigenetic) and transcriptomic data to predict biological age and distinguish disease from control samples. Using this model, the team identified dual-purpose targets such as APLNR and IL23R, with both anti-aging and anti-age-related-disease potential. The results were published in Aging, a leading journal in the field.

Insilico further expanded the model’s capabilities from evaluation and prediction to conditional generation. Released in 2024, Precious2GPT fused a Conditional Diffusion model (CDiffusion) with a decoder-only Multi-Omics Pre-trained Transformer (MoPT), capable of generating high-quality synthetic multi-omics data carrying specific tissue and age characteristics. The model’s age prediction accuracy on generated data outperformed baseline models such as conditional GANs. This research was published in npj Aging, a Nature portfolio journal.

That same year, Insilico collaborated with the Vadim N. Gladyshev Lab at Harvard Medical School to release Precious3GPT. As a true multimodal Transformer, the model integrated text, tabular data, and knowledge graph representations, covering four species, including mouse, rat, monkey, and human, and three omics modalities: transcriptomics, methylation, and proteomics. It could perform cross-species age prediction, target discovery, disease/tissue/sex classification, and compound sensitivity prediction within a unified framework. Its synthetic data generation used “biological age” as one of the conditional inputs, ensuring that generated omics data carried age and time labels. The model was open-sourced on Hugging Face and GitHub concurrent with its release as a bioRxiv preprint.

From early single-target identification and validation to the evolution of multimodal foundation models, this research lineage progressively widened the boundaries of what a single model could learn about biological systems, ultimately converging on systematic modeling of the cell’s full lifecycle and dynamic processes.

“Biology unfolds across time and interconnected levels, yet many computational models examine only one layer or moment in isolation,” said Petrina Kamya, Ph.D., Vice President, Global Head of AI Platforms and President of Insilico Medicine Canada. “VAC is designed to bring those dimensions together, combining biological age with multi-agent reasoning to explore how changes in a cell’s age affect tissues, organs, and the broader organism. Our goal is to create a more dynamic environment for studying disease, evaluating interventions, and finding new opportunities for drug discovery.”

Agentic AI Driven: From Molecular Simulation to Organism Evolution

While the PreciousGPT model series laid the foundational data and conditional generation capabilities for understanding cellular omics and aging mechanisms, the VAC platform released today introduces a Multi-Agent Swarms architecture, granting it genuine intelligent reasoning capabilities to simulate dynamic living systems.

Unlike most industry approaches that treat the cell as a “static snapshot” at a particular moment, cells in living organisms exist within a network of multi-scale interactions and continuous dynamic evolution. To capture this biological complexity, Insilico constructed a multi-agent collaborative architecture VAC platform, redefining the computational biology paradigm across three core dimensions:

Biological time as a core condition. Unlike static expression profile prediction, the multi-agent architecture treats “biological age” as the core conditional variable that penetrates every scale. When reasoning about cell differentiation, reprogramming, or disease progression, the agent swarm can dynamically assess the differential responses of tissue microenvironments across young, mature, and aged life stages, ensuring that biological time naturally permeates every reasoning step.

Six-scale agent swarm collaboration. Rather than attempting to compress all biological data into a single Transformer or graph neural network, the VAC system deploys agent swarms spanning different functions and scale gradients. Master Agents handle global task scheduling and cross-level logic integration, while Specialist Agents execute specialized tasks at each level. Individual agents can independently access databases, omics tools, and literature knowledge graphs, and engage in adaptive negotiation and joint reasoning across six biological scales — molecular, intracellular, intercellular, tissue, organ, and organism.

From state observation to fate intervention. Traditional virtual cells are largely limited to one-directional state description and expression profile imputation. The VAC platform, by contrast, is designed to answer the question “how to reverse and reshape cell fate.” When the system simulates interventions such as drug-target inhibition, gene knockout, or specific environmental stimuli, agents at each level can reason in real time about microenvironment changes, downstream pathway cascades, and cross-scale structural remodeling from micro to macro — providing end-to-end reasoning for stem cell reprogramming and systemic anti-aging strategies.

“What distinguishes VAC is not the number of hierarchical levels or agents, but the combination of bidirectional Master Agent coordination and first-class organism context storage. Among the papers we surveyed, no existing system simultaneously possesses these features: six biological hierarchies, an agent for every biological entity, dual top-down and bottom-up Master Agents, and a shared organism context that prioritizes age as a variable. The preview we are going to release is an important step toward a virtual cell that can model not just states, but changes.” Vladimir Naumov, Ph.D., Head of TargetID of Insilico Medicine.

By deeply fusing the omics perception capabilities of the PreciousGPT foundation models with the cross-scale reasoning capabilities of the VAC multi-agent architecture, the VAC platform achieves a leap from single-omics “snapshot” characterization to “dynamic biological system simulation” spanning health and disease states — providing a highly interpretable digital testing environment for target identification, cell reprogramming protocol design, and anti-aging drug evaluation.

Platform Preview and Future Horizons

With the launch of the Virtual Aging Cell Webpage, Insilico has released an initial demo preview video of the VAC platform. Additionally, Insilico will continue the conversation at ARDD 2026 (the 13th Aging Research and Drug Discovery Conference) in Boston, engaging with top academic and industry partners in the longevity research field on the next steps in virtual cell platform development, and sharing the latest practices and validations of multimodal foundation models and multi-agent systems in aging intervention, cell reprogramming, and target discovery.

As an AI-native company, Insilico is setting industry records by redefining the efficiency and scalability of drug discovery through its advanced AI platform and automation lab. While traditional early-stage drug discovery typically spans 2.5 to 4 years, Insilico consistently reaches developmental candidate (DC) nomination in an average of just 12 to 18 months, synthesizing and testing only 60 to 200 molecules per program.

Since 2021, the company has nominated 33 PCCs, 13 of which have received IND approvals or clearances. Notably, 9 of these DC nominations have been announced since the beginning of 2026, including 2 candidates originating in the UAE, the first milestone in the region’s history. These achievements fully demonstrated the scalability and efficiency of Insilico’s AI-driven R&D productivity.

Building on this AI-driven momentum, Insilico has successfully achieved clinical validation for multiple AI-discovered and AI-designed molecules generated by its Pharma.AI platform. Its most advanced program, Rentosertib, completed a Phase IIa clinical trial establishing proof of concept for safety and efficacy trends, with landmark findings published in Nature Medicine in March 2025.

This track record, combined with the vast repository of proprietary data accumulated through its R&D engine, provides robust, real-world grounding for the Virtual Aging Cell platform’s dry-lab and wet-lab validation loop and target authenticity.

For more information about Insilico’s Virtual Aging Cell, please visit: https://virtualcell.insilico.com .

About Insilico Medicine

Insilico Medicine is a pioneering global biotechnology company dedicated to integrating artificial intelligence and automation technologies to accelerate drug discovery, drive innovation in the life sciences, and extend healthy longevity to people on the planet. The company was listed on the Main Board of the Hong Kong Stock Exchange on December 30, 2025, under the stock code 03696.HK.

By integrating AI and automation technologies and deep in-house drug discovery capabilities, Insilico is delivering innovative drug solutions for unmet needs including fibrosis, oncology, immunology, pain, and obesity and metabolic disorders. Additionally, Insilico extends the reach of Pharma. AI across diverse industries, such as advanced materials, agriculture, nutritional products and veterinary medicine.

For more information, please visit www.insilico.com

View original content:https://www.prnewswire.com/news-releases/insilico-medicine-introduces-biological-age-into-virtual-cell-research-launches-virtual-aging-cell-webpage-and-previews-multi-agent-driven-vac-generation-platform-302851856.html

SOURCE Insilico Medicine

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

FouAnalytics announces global availability of in-situ screenshots for proper governance of digital campaigns

Published

on

By

NEW YORK, Aug. 14, 2026 /PRNewswire/ — FouAnalytics today announced the global availability of its in-situ screenshot capability, giving advertisers, agencies and media buyers direct visual evidence of where their digital ads rendered across websites and mobile apps, and a practical new tool for the proper governance of digital campaigns.

Digital advertising has long suffered from an accountability gap. Campaign reports may show impressions, clicks, viewability rates or invalid-traffic percentages, yet advertisers often cannot see the actual page or app environment in which their ads appeared, or confirm whether the creative rendered on screen at all. FouAnalytics’ in-situ screenshots are designed to close that gap with evidence captured at the moment an ad loads.

Unlike conventional approaches that rely on crawling a page after the fact with a headless browser, FouAnalytics captures an image of the advertiser’s ad and its surrounding page or app context in real time. Because the screenshot is taken while the ad is served, it shows the actual creative, the placement environment, and the conditions under which the ad appeared.

“In-situ means observing something in its original location,” said Dr. Augustine Fou, founder of FouAnalytics. “For advertisers, that means being able to see their own ads where they actually rendered, not a reconstruction from a separate crawl or a black-box percentage in a report. This is what we mean by ‘see Fou yourself.'”

The premium capability is available globally as part of FouAnalytics’ in-ad measurement offering. The FouAnalytics in-ad tag rides with the ad creative and does not require publishers or websites to add code. The approach is designed to provide marketers with visual transparency while creating zero load and zero latency on the publisher’s site.

Each captured image provides a visual record of the placement, including the advertiser’s creative and the surrounding webpage or mobile-app environment. Time markers can show when the screenshot was captured after ad load, helping teams assess render behavior rather than relying only on reported delivery metrics. Views can be filtered to focus on the ad itself or on the placement environment, enabling users to review the sites and apps where campaign dollars were spent. The included chart shows two examples of ads fully rendering on screen (left 2) and one example where 0% of the ads rendered on screen (rightmost).

“The team has been using FouAnalytics for years,” said Paras Shah, Senior Director, Digital Media at Georgia-Pacific. “Not only has FouAnalytics enabled us to optimize our campaigns away from fraud and towards humans, it helps us do proper governance for all our digital ad spend. For example, in-situ “live” screenshots lets us check that our ads fully rendered on-screen and see where they went, exactly.”

With this level of evidence, advertisers can identify questionable or unsuitable placements, evaluate inventory quality, document delivery discrepancies, and make more informed decisions about media partners and budget allocation. In-situ screenshots can also support stronger collaboration among media, analytics, brand-safety, procurement, and finance teams by providing a common, inspectable record of what was delivered.

FouAnalytics is the only remaining, truly independent digital advertising analytics platform designed to help advertisers measure actual campaign quality and outcomes. Its technology is intended to move measurement beyond limited invalid-traffic reporting toward greater transparency into where ads go, whether they render, and what users may actually encounter.

For more information about FouAnalytics in-situ screenshots or to request a demonstration, contact FouAnalytics at augustine.fou@fouanalytics.com

About FouAnalytics

Created by Dr. Augustine Fou, FouAnalytics is the most trusted, and the only truly independent analytics platform for digital ads, websites, and mobile apps. The platform provides detailed analytical data so practitioners can “see Fou themselves”™ why something is “high humanness,” and troubleshoot what is not good quality. Today FouAnalytics is used globally by advertisers like Microsoft, Beiersdorf and Georgia Pacific, independent agencies and every agency holding company, as well as more than 10,000 SMBs and site owners. More details at www.fouanalytics.com.

Media Contact

Dr. Augustine Fou, CEO, FouAnalytics

augustine.fou@fouanalytics.com | (212) 203-7239

View original content to download multimedia:https://www.prnewswire.com/news-releases/fouanalytics-announces-global-availability-of-in-situ-screenshots-for-proper-governance-of-digital-campaigns-302852060.html

SOURCE FouAnalytics

Continue Reading

Technology

SPYKER C8 PRELIATOR XXV COUPÉ 146 YEARS IN THE MAKING. A NEW ERA BEGINS.

Published

on

By

SPYKER UNVEILS THE C8 PRELIATOR XXV COUPÉ, MARKING A NEW ERA FOR THE 146-YEAR-OLD DUTCH MARQUE

AMSTERDAM and CARMEL, Calif., Aug. 14, 2026 /PRNewswire/ — Spyker today unveils the Spyker C8 Preliator XXV Coupé, marking the beginning of a new era for the storied marque. The hand-built flagship hypercar, chassis number 270, pairs an 800-horsepower twin-turbo engine with a true manual gearbox and a handmade aluminum body, continuing Spyker’s coachbuilding tradition as it returns to The Quail during Monterey Car Week.

Far more than the evolution of an existing model, the Spyker C8 Preliator XXV Coupé is an entirely new automobile. Conceived from a clean sheet of paper, it combines uncompromising craftsmanship, aviation-inspired engineering and modern performance while remaining faithful to the design philosophy that has defined Spyker since the beginning: creating automotive art in motion, its designs akin to an aircraft for the road.

That idea is more than a metaphor. Aviation has been part of Spyker’s DNA since the company merged with the Dutch Aircraft Factory in 1914, influencing generations of its design and engineering. That lineage crystallized in 1919 with the Spyker C1 Aerocoque, the car that gave rise to an idea that still defines the company.

Spyker’s story began in the Netherlands in 1880, when brothers Hendrik Jan and Jacobus Spijker founded the company as coachbuilders manufacturing their very first car in 1898. In 1903, the brothers built the world’s first six-cylinder, four-wheel-drive car and showed it in London and Paris. In 1907, a Spyker raced from Peking to Paris, sponsored by Louis Vuitton, and finished second over roughly 15,000 kilometers of unchartered terrain.

These roots have taken a different shape in each generation of Spyker’s modern era, which began with the company’s revival in 2000. The first cars of that era, the Spyker C8 Spyder, C8 Laviolette and C8 Double12, carried aviation-style air intakes, propeller-inspired wheel rims, and an aviation dashboard. The Spyker C8 Aileron, introduced in 2009, moved the design language closer to a fighter jet, with turbine air intakes and turbine wheels. The Spyker C8 Preliator XXV Coupé has NACA ducts as air intakes, pushing the aviation concept further still and carries that evolution to its third generation: where a fin tail has so far been a subtle nod, first appearing on the 2006 Spyker D12 Peking-to-Paris, the Spyker C8 Preliator XXV Coupé brings it back in a bold way, echoing the prominent fin tail of the original 1919 Spyker C1 Aerocoque. The Spyker C8 Preliator XXV Coupé headlights carry the model’s own name: XXV, and its rear lights are shaped like fighter jet afterburners.

An aerospace idea runs through the smaller details as well: an isogrid lattice of interlocking triangles, developed to make rocket structures lighter whilst making them even stronger, appears in the car’s grilles, vents, pedals, exhaust mesh, and seat upholstery, engineering and design speaking the same language throughout. And then there is Spyker’s unmistakable exposed gear linkage, a signature Spyker design element from day one.

The body is hand-built in aluminum, on a spaceframe engineered entirely in-house and completely redesigned for this car, continuing Spyker’s long partnership with the craftsmen of Coventry Prototype Panels in England, where every exterior panel was newly shaped for the Spyker C8 Preliator XXV Coupé.

A Spyker takes roughly 2100 hours to build this way. The steering wheel is stitched with two needles at once, by one craftsman, over four hours. The dashboard in turned aluminum is a nod to the pre-1925 Spykers, milled by a workshop that has finished automotive parts since the same decade Spyker was founded in 1880. Even the screw heads inside the cabin are aligned by hand to face the same direction, a detail no owner will likely ever notice, which is precisely the point. Each chassis number is stamped by hand into the aluminum space frame, so that no two impressions are quite alike. The car on display at The Quail is chassis number 270, the last of 255 Spykers built since 2000. The car is finished in a vivid metallic Quail Green with subtle rose gold flakes, its brightwork finished in rose gold throughout, and its interior trimmed in a rich orange-brown leather the company calls Tuscan Saddle.

In an industry where carbon fiber has become the default, Spyker deliberately continues to work in aluminum. Not as a compromise, but because aluminum can be shaped, worked and polished by hand. It carries the touch of the craftsman and gives every car an individuality that cannot be replicated by an automated production process. 

Said Spyker Founder and CEO Victor Muller, “While carbon fiber is rightfully celebrated for its technical virtues, we have always preferred aluminum, a living metal that can be shaped by the hand of an experienced craftsman, polished to perfection, its beauty only deepening with age, like a fine Cabernet. For Spyker, this is what modern ultra-luxury should feel like: rare, personal, and made by human hands.”

At the heart of the C8 Preliator XXV Coupé is a 4.0-liter twin-turbo V8 producing 800 horsepower and 1,000 Nm of torque, with a top speed exceeding 217 mph. But the C8 Preliator XXV Coupé was never conceived around numbers alone. Unlike virtually every contemporary hypercar, it is equipped with a true manual gearbox. There are no shift paddles or automated substitutes. Every gear change remains a direct, mechanical interaction between driver and car. The same philosophy carries through to the cockpit. Digital interfaces are kept to a minimum, with a head-up display as the only screen. Everything else remains deliberately analogue, tactile and designed to be operated rather than watched.

Added Muller, “We deliberately chose a real manual transmission, not an automated imitation. You decide when to shift. You feel every gear change in your hand. And if you make a mistake, well, you bear the consequences. That is what driving a sports car should be, at least according to Spyker.”

Underneath, the fuel tank has been moved from the sills to a trapezoidal space behind the seats and ahead of the engine, a placement long used on Spyker’s Le Mans race cars and now brought to the road. The rear boot has been moved entirely to the front. In its place, the so-called butterfly mode, the entire car opens at the push of a button, as the earliest Spykers did, which means the engine bay itself had to be designed to the same standard as the rest of the car, a detail the company has compared to the movement of a fine Swiss Watch.

That craftsmanship draws on a hundred and forty-six years of company history. The car’s name, in Latin, means “warrior.” The label suits a marque that has lived by the same motto since 1914: Nulla Tenaci Invia Est Via, for the tenacious, no road is impassable.

Production of the C8 Preliator XXV Coupé will be limited to just 25 hand-built hypercars. Each will be individually commissioned, making every C8 Preliator XXV Coupé not simply a collector’s car, but a personal expression of its owner and a piece of Spyker history.

Looking Towards the Future

But the C8 Preliator XXV Coupé is not simply a celebration of Spyker’s past. It is the starting point for what comes next. Its debut marks the beginning of a new era for Spyker following Volodymyr Nosov’s investment and his becoming co-owner of the marque, and a strategic partnership with W Group, a major European fintech group specializing in blockchain technology and digital infrastructure. 

The partnership brings together two worlds: 146 years of automotive heritage, craftsmanship and engineering with technological expertise, digital capabilities, and a forward-looking approach to building global businesses.

The ambition is not simply to bring a legendary automotive marque back. It is to build the next era of Spyker. That does not mean changing what makes a Spyker a Spyker. Spyker is not becoming a digital device on wheels. The hypercars will remain analogue.

Instead, technology will strengthen the world around the car. W Group’s technological capabilities and digital infrastructure will support the development of new client experiences, a broader digital ecosystem and new ways for Spyker to engage with owners and collectors around the world. 

The principle is simple: preserve what makes Spyker timeless and use technology to build what comes next. The C8 Preliator XXV Coupé is the first expression of that vision. Spyker’s next chapter is expected to include the development of the Spyker D8 Peking-to-Paris SSUV, new digital and client experiences, and ambitions to return to endurance GT3 racing. 

“The launch of this new hypercar marks a new era for Spyker. The partnership with Volodymyr Nosov underlines the long-term ambitions of the brand and its shareholders. We are building on everything that has made Spyker distinctive for 146 years while creating the foundation for what comes next. Spyker’s future has never looked brighter, and I am immensely proud of the employees, partners and suppliers who put their faith in us,” said Muller.

Volodymyr Nosov, Co-owner of Spyker and Founder and President of W Group, said,
“We are bringing together more than a century of Spyker’s automotive heritage with W Group’s technological expertise, ambition and forward-looking mindset. Our goal was never simply to bring a legendary name back. We want to build the next era of Spyker, preserving everything that makes the marque iconic while opening it to new technologies, new experiences and a new generation of clients. The C8 Preliator XXV Coupé is the first statement of that ambition. And this is only the beginning.”

Following its world debut at The Quail, the C8 Preliator XXV Coupé will appear on the Concept Car Lawn at the Pebble Beach Concours d’Elegance on August 16.

About Spyker
Founded in 1880 in the Netherlands, Spyker is one of the world’s oldest ultra-luxury automotive brands, hand-building exclusive hypercars to individual commission. The brand’s rich heritage includes creating the world’s first four-wheel-drive car in 1903, building planes from 1914 to 1918, and participating in Formula One and the 24 Hours of Le Mans. Today, the company produces vehicles exclusively in extremely limited numbers featuring aviation-inspired design elements.

About W Group
W Group is a major European fintech group specializing in blockchain technology and digital infrastructure. Its ecosystem is built to make blockchain and digital assets secure, accessible and easy to use, serving more than 40 million users across 150 countries worldwide. At the heart of W Group is WhiteBIT, the largest European cryptocurrency exchange by traffic.

Contact:
Suzanne Wellington 
Shamin Abas Associates 
suzanne@shaminabas.com 
+1 (404) 543-3623. 
For a high-resolution image, click here.

View original content to download multimedia:https://www.prnewswire.com/news-releases/spyker-c8-preliator-xxv-coupe-146-years-in-the-making-a-new-era-begins-302851324.html

SOURCE Spyker

Continue Reading

Technology

U.S. Workers Know They Must Adapt but Action Is Stalling, New ETS Report Reveals

Published

on

By

2026 ETS Human Progress Report — 50 States Edition reveals “adaptability paralysis,” with 78% of U.S. workers saying job security no longer exists without continuous adaptation, yet proactive upskilling trailing global peers

PRINCETON, N.J., Aug. 14, 2026 /PRNewswire/ — U.S. workers overwhelmingly recognize that adaptability is now the foundation of job security, but time, cost, access and employer support are preventing awareness from turning into action, according to the 2026 ETS Human Progress Report — 50 States Edition, released today by ETS.

The report, based on a survey of more than 15,000 U.S. adults across all 50 states and the District of Columbia, finds that 78% of U.S. workers agree job security no longer exists without continuous adaptation, and 85% say upskilling or reskilling is no longer a choice but a necessity. Yet only 71% report proactively developing new skills — trailing the global average of 77% but far behind high-growth markets such as India (89%) and China (80%).

“America’s workers are ready to adapt, but too many are being asked to do it without the time, resources or roadmap they need,” said Amit Sevak, CEO of ETS. “That cannot be the worker’s burden alone. Governors and CEOs have a shared responsibility to make workforce readiness a priority in every state and every organization, by investing in trusted credentials, measuring practical skills and building clear pathways that help people stay relevant, advance and compete in the economy ahead.”

Key national findings

Workers feel underprepared. 54% of U.S. workers say they feel underprepared for the next generation of jobs (vs. 49% globally), and 75% say they have no clear picture of what jobs will look like in 2035.

AI disruption is already underway and uneven. U.S. workers estimate 26% of their work currently involves AI and expect that to rise to 43% within two years. Current AI usage at work ranges from 47% in Alaska to 18% in Maine and Wisconsin, creating a new divide as AI exposure increasingly determines opportunity.

The emotional toll is real. 58% of U.S. workers report a fear of becoming obsolete (FOBO), rising to 74% among technology workers and 73% in financial services. 54% say their priorities have shifted from seeking job security to staying relevant.

Barriers are stacking up. 68% of U.S. respondents say upskilling costs are difficult to cover, 63% struggle to find time to learn while maintaining their workload, and 57% find it difficult to get employer support. While 67% are interested in credentialing programs, only 41% have access to them — a 26-point gap.

Americans seek support from trusted channels. 71% want government help in mastering workforce-readiness skills, and 89% agree employers should encourage workers to set credential goals throughout their careers. Trust in credentialing organizations and employers (43% each) outpaces trust in state/local (30%) and federal (28%) government as assessment providers.

State-level pressure points

The report finds the conditions for adaptability vary sharply by state. Maine, Hawaii and Pennsylvania stand out with workers reporting the greatest difficulties across multiple upskilling barriers, while workers in Alaska, the District of Columbia and Delaware report the fewest obstacles. Delaware leads the nation with 89% of workers saying they are proactively developing new skills, followed by Alaska (87%) and the District of Columbia (83%).

The education-to-workforce gap also emerges as a national theme: 61% of employed U.S. college graduates say their university did not adequately prepare them for the workforce, and 90% of U.S. respondents agree educational assessments should measure both academic knowledge and practical skills.

The U.S. scores 93.7 on the 2026 ETS Human Progress Index, below the global index of 96.7, indicating Americans perceive greater difficulty accessing education, upward mobility and upskilling than their global peers.

A call to action

The report identifies three priorities for building a future-ready U.S. workforce: employers turning expectations into clear credential pathways; governments funding access through trusted credentialing partnerships; and educators bridging learning and workforce readiness by integrating practical skills assessment.

To explore the full findings and to learn more, download the 2026 ETS Human Progress Report — 50 States Edition.

Methodology

The survey was conducted online by The Harris Poll on behalf of ETS from August 25 to September 10, 2025, among 15,357 U.S. adults aged 18 or older, with a minimum of 300 respondents per state and the District of Columbia. Data is weighted to reflect U.S. Census demographic distribution. Global comparisons are drawn from the global 2026 ETS Human Progress Report dataset of 32,558 adults across 18 countries.

About ETS

ETS is a global education and talent solutions organization enabling lifelong learners to be future ready. Our mission – advancing the science of measurement to power human progress – ensures our focus to enable everyone, everywhere, to demonstrate their skills and chart their path to future readiness for life. We are committed to readying 100M+ people for the next generation of jobs by 2035. We deliver on this commitment through trusted assessments and skills solutions – including TOEFL, TOEIC, GRE, Praxis and Futurenav – and groundbreaking initiatives powered by our Research Institute. With a robust global footprint, including subsidiaries (PSI), offices and operations in more than 200 countries and territories, we help over 50 million individuals each year measure their proficiency and unlock new opportunities. Discover how we expand our worldwide impact: www.ets.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/us-workers-know-they-must-adapt-but-action-is-stalling-new-ets-report-reveals-302851898.html

SOURCE ETS

Continue Reading

Trending